Insider · CIK 0001816992

Caffo Nathan

Reports to the SEC for 2 companies · BURLINGAME, CA

Transactions

Companies

Filings

CIK

0001816992

Forms 4 and 5

Insider transactions

4 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-07-29	CADLCandel Therapeutics, Inc.P Purchase	Chief Business Officer	PPurchase	+6,000 sh	$8.00	+$48K	6,000
2020-07-21	ALXOALX ONCOLOGY HOLDINGS INCC Conversion	Chief Business Officer	CConversion	+10.5K sh	—	—	11,254
2020-07-21	ALXOALX ONCOLOGY HOLDINGS INC · Series B Convertible Preferred StockC Conversion	Chief Business Officer	CConversion	−10.5K sh	—	—	0
2020-07-16	ALXOALX ONCOLOGY HOLDINGS INC · Employee Stock Option (right to buy)A Award	Chief Business Officer	AAward	+22.8K sh	—	—	22,794

C/O ALX ONCOLOGY HOLDINGS INC. 866 MALCOLM ROAD, SUITE 100

BURLINGAME, CA, 94010